Skip to main content
ANAB
NASDAQ Life Sciences

AnaptysBio Soars to 52-Week High Post-Spinoff; First Tracks Biotherapeutics Shares Decline

Tom Rudovsky · Reported by Dow Jones Newswires
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$50.415
Mkt Cap
$1.449B
52W Low
$11.402
52W High
$51.43
52W Position info
342% above low
Off High info
2.0% below high
Rel. Volume info
0.7× avg
Market data snapshot near publication time

ANAB has more than doubled off its 52-week low of $11.402.

Summary

AnaptysBio shares surged to a 52-week high, rising 11% to $50.13, following the successful completion of its spin-off of First Tracks Biotherapeutics. This event, which saw AnaptysBio distribute shares of First Tracks to its stockholders, marks a significant corporate restructuring. The market's strong positive reaction to AnaptysBio suggests approval of its new focus on managing royalties from existing financial collaborations. Conversely, First Tracks Biotherapeutics, now focused on developing antibodies for autoimmune diseases, saw its shares decline 21% to $17.86. This news provides crucial, immediate market feedback on the strategic separation and the perceived value of the resulting independent companies.

At the time of this announcement, ANAB was trading at $50.42 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $1.4B. The 52-week trading range was $11.40 to $51.43. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: Dow Jones Newswires.


Price Chart

Share this article

Copied!

ANAB - Latest Insights

ANAB
Nov 12, 2026, 4:21 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $47.77
Real-time Price: $46.25 info
Change: -$1.52 (-3%) info
Market Cap: $1.383B info
ANAB
Nov 12, 2026, 4:16 PM EST
Source: Reuters
Importance Score:
7
Price at Filing: $47.77
Real-time Price: $46.25 info
Change: -$1.52 (-3%) info
Market Cap: $1.383B info
ANAB
Oct 20, 2026, 3:49 PM EDT
Source: Seeking Alpha
Importance Score:
7
Price at Filing: $45.00
Real-time Price: $46.25 info
Change: +$1.25 (+3%) info
Market Cap: $1.383B info
ANAB
Oct 19, 2026, 2:18 PM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $49.23
Real-time Price: $46.25 info
Change: -$2.98 (-6%) info
Market Cap: $1.383B info
ANAB
Sep 28, 2026, 7:00 AM EDT
Source: Wiseek News
Importance Score:
8
Price at Filing: $50.85
Real-time Price: $46.25 info
Change: -$4.60 (-9%) info
Market Cap: $1.383B info